tirzepatide weight loss percent The weight-loss drug that melts the most fat is not the one proven to save lives. In the largest head-to-head to date, a network analysis of 262 randomized trials and 99,791 people Semaglutide vs Tirzepatide: Which GLP-1

FDA issued more than 58 warning letters addressing false or misleading claims about compounded GLP-1 products including compounded semaglutide and tirzepatide through late 2025 and early 2026, and followed with 30 further warning letters to telehealth companies in a single coordinated action in June 2026. In September 2025, the FDA also introduced a Green List import alert targeting active pharmaceutical ingredient (API) sources for GLP-1 products, restricting entry for foreign API manufacturers that have not demonstrated GMP compliance. Together, these actions show how quickly enforcement attention can pivot to a single product category a pattern directly relevant to any organization with exposure to compounding, telehealth-linked supply, or GLP-1 API sourcing

To make sure their products are of high quality, companies should include clear directions on how to use them, tips about when not to use them, and ways to record bad events

Youll see why where you get care matters just as much as what treatment you choose

Please recycle